Lung Cancers Recruiting Phase 2 Trials for Carboplatin (DB00958)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03256136Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLCTreatment
NCT02513563AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung CancerTreatment
NCT03706703Rh-Endostatin (Endostar®) Continuous Intravenous InfusionTreatment
NCT03164694APatinib Plus Chemotherapy vErsus Chemotherapy As First-line Treatment for Advanced NSCLCTreatment
NCT02428764Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung CarcinomaTreatment